Home / Inspections / 1063019

FDA Inspection 1063019 — Generics Bidco II LLC

Generics Bidco II LLC — FEI 1038197

The FDA completed an inspection of Generics Bidco II LLC on July 13, 2018 in Charlotte, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 13, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Charlotte, NC (United States)

Facility

Other inspections at this facility

  • 1282440 (VAI Fri Sep 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122274 (NAI Wed Mar 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 987950 (NAI Wed Aug 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 942172 (NAI Thu Apr 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 879391 (NAI Wed May 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources